Business Context and Reporting Period
This Form 8-K Current Report was filed by AquaBounty Technologies, Inc. on November 22, 2021, regarding events occurring on November 18 and 19, 2021. The Company, an emerging growth company incorporated in Delaware, operates in the aquaculture sector. The filing primarily addresses a secondary public offering of common stock by selling shareholders.
Key Financial Metrics and Transaction Details
The filing details a secondary offering rather than a primary capital raise for the Company. Key transaction metrics include:
- Shares Offered: 11,200,000 shares of Common Stock.
- Offering Price: $2.10 per share.
- Over-Allotment Option: Underwriters fully exercised the option to purchase an additional 1,680,000 shares.
- Total Shares Sold: 12,880,000 shares (including over-allotment).
- Proceeds to Company: $0. The Company will not receive any proceeds from this transaction.
- Costs: Selling shareholders bear all costs, including underwriting discounts and commissions.
The filing text does not provide current revenue, profit, cash flow, margin, debt, or liquidity figures for the Company.
Material Changes and Agreements
On November 19, 2021, the Company entered into an Underwriting Agreement with Oppenheimer & Co. Inc. and Lake Street Capital Markets, LLC. A material change resulting from this agreement is a 90-day lock-up period. Subject to certain exceptions, the Company agreed not to offer, issue, or sell any shares of Common Stock or convertible securities without the prior written consent of the underwriters for 90 days following the offering.
Outlook, Risks, and Management Commentary
The offering was expected to close on November 23, 2021, subject to customary closing conditions. The transaction was conducted pursuant to a registration statement on Form S-3 filed in August 2021. The filing notes standard indemnification obligations and termination provisions within the Underwriting Agreement but does not provide specific management commentary on future business outlook, risks, or contingencies beyond the standard terms of the underwriting agreement.
Investor Verification Checklist
- Verify the final closing date of the offering (expected November 23, 2021) and confirm the full exercise of the over-allotment option.
- Confirm the identity of the Selling Shareholders to assess potential dilution impact on existing shareholders.
- Review the 90-day lock-up agreement terms to understand restrictions on future capital raises by the Company.
- Check subsequent filings for the Company's actual cash position, as this transaction generated no proceeds for the Company.